Study of Nelonemdaz

GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

Yongin, South Korea:  Safety and Tolerability Established Good and Excellent Functional Outcome Increased  GNT Pharma Inc. today reports positive top-line results…

Read More »